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Abstract
 Allergic and immunologic diseases very often manifest oral lesions in their earliest 
stages, an early diagnosis, which may be spurred by a dental examination, is a key for 
improved outcomes. After systemic diagnosis, oral lesions benefi t from special care 
by dentists in alliance with the medical team. This review aims to highlight the most 
relevant allergic and immunologic conditions of the oral cavity, their pathogenesis, and 
their pathognomonic diagnostic features, which will navigate the clinicians to arrive at a 
prompt diagnosis and subsequent management.
Introduction
An allergy is defi ned as an altered or changed response of the 
immune system to foreign proteins. The term “allergy” was 
conceived by Clemens von Pirquet in 1906. Allergens are foreign 
substances that initiate allergic reactions. They enter the body 
by inhalation, swallowing, injection, contact with the skin, oral 
mucosa, and eye.[1]
The oral cavity is subjected to a wide spectrum of antigenic 
agents-foodstuﬀ s, microorganisms, cosmetics, drugs, dental 
materials including restorative materials, toothpaste. Despite high 
oral bacterial colonization and periodic allergen contact, acute 
allergic and immunologic reactions are rare because the immune 
resistance outweighs the allergen attack. Moreover, the antigen 
presenting cells, such as dendritic cells and diﬀ erent subsets of 
T-cells, serve as key players in oral mucosal tolerance induction.[2,3]
However, there is evidence of oral allergic reactions that 
proved fatal. Allergic reactions may manifest as a localized 
vesicle or a papule, patch, ulceration, or swelling. Thus, onus 
lies on clinician, based on advances in the understanding of 
disease pathogenesis, to give an early and accurate diagnosis 
to prevent further complications. Further research and the 
emergence of immunotherapeutics will help to ameliorate 
these diseases.[2]
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• Wegener’s granulomatosis (WG)
• Uveoparotid fever.
Mechanisms of allergy [Figure 1]
Immunoglobulin E (IgE)-mediated allergy
Allergic conditions occur when individuals produce increased 
amounts of the allergic antibody IgE, which binds to specifi c 
receptors on mast cells. When the cell-associated IgE comes 
in contact with an explicit allergen across which it is directed, 
the IgE molecules become “cross-linked” to that allergen. This 
activates the mast cell and chemical infl ammatory mediators, 
such as histamine and leukotrienes, are released. Histamine 
causes acute symptoms of allergy such as itching, rash, and tissue 
swelling. Leukotrienes have a more prolonged course of action, 
causing narrowing of airways and swelling which leads to severe 
systemic manifestations.[1,3]
Non-IgE-mediated allergy
Some allergic conditions are not dependent on IgE. They involve 
an abnormal immune response to a wide range of external 
environmental agents. These conditions are known as non-
atopic (non-IgE-mediated). The mechanisms of non-atopic 
disease are less understood but may involve diﬀ erent subsets of 
immune cells known as T-helper-1 (Th1) cells.[1,3]
RAS
The name “aphthous” emerged from the Greek word “aphthae” 
which means ulceration.[5] RAS, also known as canker sores, is 
one of the most common painful mucosal conditions aﬀ ecting 
the oral cavity. RAS shows 20% prevalence in the general 
population. The peak age of onset is during early childhood, 
with a propensity to diminish in frequency and severity with age. 
The pathogenesis of aphthous ulcers is related to dysfunctions 
of the immune system.[9] The causative agent could be an 
endogenous or an exogenous antigen. They have a non-specifi c 
etiology, such as stress, trauma, and food allergies. Three 
diﬀ erent forms of aphthous ulcers have been identifi ed - minor, 
major, and herpetiform. These present as multiple, recurrent, 
small, rounded, or oval ulcers, with circumscribed margins, 
having yellow or gray fl oors, encompassed by an erythematous 
halo.[6,9,10]
Minor aphthous ulcers are 0.5-1 cm in size. They heal 
spontaneously in 7-10 days without scar formation. Major 
aphthous ulcers are larger in size (>1 cm) and are painful. They 
persist for 6-10 weeks and heal with scar formation. Herpetiform 
aphthous ulcers present as recurrent crops of small ulcers. They 
heal spontaneously in 10-14 days without scar formation.[6,7] 
These ulcers are not preceded by vesicles and characteristically 
appear on the buccal mucosa, fl oor of the mouth, tongue, and 
soft palate. Rarely do these lesions occur on keratinized mucosa-
like hard palate and attached gingiva, providing an important 
clinical sign for the diﬀ erentiation of aphthous ulcers from 
herpetic ulcers.[6,10]
Figure 1: Flowchart representing the mechanisms of allergic reactions[1,3,8]
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Key features facilitating diagnosis[5,7,9,10]
• Located in non-keratinized oral mucosa
• Not preceded by vesicle formation which diﬀ erentiates them 
from herpetic ulcers
• Histopathology shows presence of Anitschkow cells, 
consisting of cells with elongated nuclei containing linear 
bars of chromatin extending toward the nuclear membrane
• Indirect immunofl uorescence shows binding of 
immunoglobulin M and immunoglobulin G antibodies to the 
spinous layer of the epithelium
• Serum of aphthous ulcer patients shows elevated levels of 
gamma globulin.
Behcet’s disease
Behcet’s disease is a persistent infl ammatory disorder where 
recurrent oral aphthae is a consistent feature. It was fi rst 
described by Turkish dermatologist Hûlusi Behçet in 1937. Its 
exact pathogenesis remains unknown. It has been postulated 
that the disease may be prompted by environmental factors, 
such as infection, pollution, and in genetic susceptible patients. 
Studies have shown that human leukocyte antigen (HLA)-B 
51 (more than 60% of patients) is associated with Behçet’s 
disease. It consists of a triad of recurrent oral aphthous ulcers, 
genital ulcers, and ocular lesions. Relapsing polychondritis 
(e.g., auricular cartilage and nasal cartilage) in association with 
Behcet’s stigmata has been designated as the Mouth and Genital 
Ulcers with Infl amed Cartilage syndrome [Table 1].[6,11,12]
Key features facilitating the diagnosis[6,11,12]
• Presence of recurrent oral aphthae is imperative for a 
diagnosis of Behcet’s disease
• Apart from recurrent oral aphthae, presence of any two minor 
criteria is mandatory
• Patients with Behcet’s disease manifested with 
hypergammaglobulinemia, eosinophilia and elevated 
erythrocyte sedimentation rate
• Platelet rosette formation around the neutrophils is a key 
diagnostic factor during the acute phase of the disease.
Reiter’s syndrome
Reiter’s syndrome was fi rst described by Hans Reiter in 1917. 
Currently, it is stated as a secondary syndrome to microbial 
infections such as Chlamydia, Yersinia, Campylobacter, 
Salmonella, and Shigella. Pleuropneumonia-like organisms 
have also been implicated in the etiopathogenesis of Reiter’s 
syndrome.[5] Genetic predisposition, with high association of 
HLA-B27 histocompatibility, is associated with this entity.[14,15] 
The onset of Reiter’s syndrome is acute, with the simultaneous 
appearance of mucocutaneous lesions in the oral cavity along 
with urethritis, bilateral conjunctivitis, and oligoarthritis aﬀ ecting 
large and small joints of lower limbs. Other features include fever, 
weight loss, vasomotor abnormalities in the feet, and skin lesions 
consisting of faint macules, vesicles, and pustules on the hands 
and feet. Oral lesions have been described as relatively painless 
aphthous-type ulcers occurring almost anywhere in the mouth. 
Tongue lesions simulate geographic tongue in appearance.[6,7]
Key features facilitating diagnosis[5,6,15]
• History of enteric or sexually transmitted infections
• Combination of mucocutaneous oral lesions, urethritis, 
conjunctivitis, and peripheral joint dysfunction.
Oral lichenoid reaction
OLR represents a common end point to extrinsic agents (drugs, 
allergens), altered self-antigens, or superantigens.[5,6] It can 
be considered a separate entity or an exacerbation of already 
existing oral lichen planus by intake of medication or presence 
of dental material. The mechanism of development of lichenoid 
reaction remains unknown. A series of triggering factors, such as 
dental restorative materials, graft-versus-host disease, fl avoring 
agents, and tobacco chewing, is implicated in the causation of 
lichenoid reactions. Keratinocyte antigen expression induced 
by systemic drugs, mechanical trauma (Koebner phenomenon), 
and microbial infection have been implicated in the pathogenesis 
of lichenoid reaction. CD8+ cytotoxic T-cells may trigger 
apoptosis of keratinocytes through activation of the cells by an 
antigen coupled with major-histocompatibility-complex class I 
on basal keratinocytes. Pain is the most prevalent symptom. Oral 
manifestations such as metallic taste or dry mouth can also be 
observed [Table 2].[16-18]
Key features facilitating diagnosis[6,16-18]
• Unilateral or bilateral lesions
• Direct topographic relationship to the suspected etiologic 
agent
• Spontaneous remission of the lesion upon withdrawal of 
oﬀ ending material.
Contact stomatitis
It is a type of allergic reaction characterized by a lesion in the oral 
mucous membrane after repeated contact with the oﬀ ending 
agent.[6,7] These causative agents are chemical in nature 
(haptens) and require union with proteins to become eﬀ ective. 
This process occurs with help of intraepithelial dendritic 
cells which converts the hapten into a competent antigen and 
presents it to T-lymphocytes for sensitization and production of 
Table 1: Diagnostic criteria for Behcet’s disease[6,13]
Major 
criteria
Recurrent aphthous ulcers and genital lesions
Minor 
criteria
1. Arthritis or arthralgia
2. Eye lesions
3. Skin lesions (erythema-nodosum such as folliculitis)





CNS: Central nervous system
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IgE. Following antigenic re-exposure, local lymphocytes secrete 
chemical mediators of infl ammation that produce the clinical 
and histologic changes characteristic of this process. Numerous 
allergens, varying from simple chemical elements to complex 
organic substances, are implicated with the pathogenesis of this 
disease. There is a well-recognized group of materials which 
cause the oral lesion, and for this reason, they are of special 
interest to the dentist. They can be classifi ed as dental/cosmetic 
preparations such as dentifrices and mouthwashes; dental 
materials such as nickel and acrylic; dental therapeutic agents 
such as alcohol, phenol, and antibiotics. It manifests as an itching 
or burning sensation at the site of contact followed by erythema 
and vesicle formation.[20-22]
Key features facilitating diagnosis[6,20-22]
• Biopsy reveals intercellular edema of epithelium along with 
vesicle formation
• History of a chronic allergen associated with the entity
• Discontinuance of the allergen causes remission of symptoms.
Sarcoidosis
Sarcoidosis is a multifactorial disease of unknown origin fi rst 
reported by Jonathan Hutchinson in 1875. It is characterized 
by the formation of uniform, discrete, non-caseating granuloma. 
Boeck coined “sarcoidosis” which stems from the Greek words 
“sark“ (meaning fl esh) and “oid“ (meaning like) and refers 
to the fl esh-like tumors fi rst observed on the skin of aﬀ ected 
patients.[5,23] A positive association with HLA-A1, HLA-B8, 
and HLA-DR3 has been identifi ed as a putative genetic 
background in the pathogenesis of sarcoidosis. Infectious 
agents (mycobacterium, propionibacteria, Epstein-Barr virus, 
and human herpes virus-8), environmental factors (dust, 
clay, pollen mold, and silica), and occupational exposure are 
potential etiological agents. Th1 lymphocytes play a primary 
role in granuloma formation as a result of deposition of poorly 
soluble antigenic material in the tissue. Cutaneous lesions, 
present in approximately 25-35% of patients with sarcoidosis, 
may be the only distinct manifestation of the disease.[7] 
Involvement of lymph nodes or salivary glands is manifested 
by bumpy enlargement. Hepatomegaly and splenomegaly 
may occur, owing to the presence of the disease in the liver 
and spleen. In the oral cavity, the disease manifests on the lips, 
palate, and buccal mucosa. Lesions on the lips appear as small, 
papules, or plaques, resembling herpetic lesions. Lesions appear 
as bleb-like, comprising of clear yellowish fl uid, or as solid 
nodules on the palate and buccal mucosa. They may produce 
diﬀ use destruction of the bone.[23-27]
Key features facilitating diagnosis[24-26]
• Appearance of asteroid bodies in indirect immunofl uorescence
• An intracutaneous test (Kveim-Siltzbach test), using a 
suspension of known sarcoidal tissue, confi rms diagnosis.
PD
PD and light-sensitive seborrheic are synonyms for chronic 
papulopustular facial dermatitis.[6] It is an infl ammatory orofacial 
skin disorder commonly aﬀ ecting women, fi rst described by 
Frumess and Lewis in 1957. Its etiology remains unknown. 
Overzealous use of topical steroids and cosmetics often precedes 
manifestation of the disease. Use of inhaled steroid sprays into 
the nose and mouth can also precipitate PD. Physical factors 
such as UV light, heat, and wind worsen PD. Investigators believe 
the infections may arise from fusiform spirilla bacteria, Candida 
species, and Demodex folliculorum. Hormonal factors are suspected 
because premenstrual deterioration has been observed. The 
disease presents with follicular reddish papules, papulovesicles, 
and papulopustules in the perioral region. Predominantly aﬀ ected 
sites are the perioral area around the lips, nasolabial fold, and 
lateral portions of lower eyelids. A frequent feature of PD is a 
border of normal skin separating lesional skin from the lips.[7,28,29]
Key features facilitating diagnosis[6,28,29]
• Histopathological examination reveals early papular lesions 
with eczematous changes consisting of parakeratosis and 
mild acanthosis
• History of prolonged usage of corticosteroids or overzealous 
use of cosmetics is a marker for diagnosis
• Disappearance of symptoms upon removal of the oﬀ ending 
agent.
WG
WG, fi rst described by Friedrich Wegener in 1936, is a chronic 
relapsing granulomatous disease.[30] It involves the oral cavity, 
Table 2: Comparison of clinical and histopathological oral lichen planus and oral lichenoid reaction[16,19]
Features Oral lichen planus Oral lichenoid reaction
Clinical features 1. Presence of bilateral, more or less symmetrical lesions
2.  Presence of a lacelike network of slightly raised 
gray-white lines (reticular pattern)
3. No evidence of any etiologic agent
1. Presence of unilateral or bilateral lesions
2.  Presence of a lace-like network of slightly raised gray-white 
lines (reticular pattern)
3. Evidence of an etiologic agent
Lesions resolve on withdrawal of etiologic agent
Histopathological 
features
1.  Presence of a well-defi ned band like zone of cellular 
infi ltration that is confi ned to the superfi cial part of the 
connective tissue, consisting mainly of lymphocytes
2. Signs of liquefaction degeneration in the basal cell layer
3. Absence of epithelial dysplasia
1.  Presence of a well-defi ned band like zone of cellular 
infi ltration that is confi ned to the superfi cial part of the 
connective tissue, consisting of lymphocytes and eosinophils
2. Liquefaction degeneration of the basal cell layer
3. No evidence of epithelial dysplasia
International Journal of Clinical Dental Science ● Vol. 6:1 ● 2016 5
Ghosh, et al. Oral mucosal allergy
vascular, renal, and respiratory systems. WG can occur at any 
age although majority of cases are seen in the fourth and fi fth 
decades of life with a slight male predilection.[30-32] Its exact 
etiology remains unknown. Investigators believe the disease 
is caused by an atypical immune reaction to a non-specifi c 
infection or a hypersensitivity reaction to an unknown antigen. 
Infl ammation in WG is due to the formation of antineutrophil 
cytoplasmic antibody (ANCA). ANCA-mediated vasculitis 
involves the interaction of polymorphonuclear neutrophils 
and endothelial cells via cell adhesion molecule interactions.[33] 
Classically, WG comprises a triad of vascular, lung, and kidney 
infection. Involvement of the oral cavity occurs with considerable 
frequency. Gingival involvement is the most common and 
characteristic manifestation and is termed strawberry gingivitis. 
The infl ammatory process begins in the interdental papilla and 
spreads to the periodontium leading to bone loss and tooth 
mobility. Ulceration of palate is a frequent feature followed by 
extension of the disease to the nose, resulting in destruction of 
the nasal septum.[6,32,33]
Key features facilitating diagnosis[6,7,32,33]
• Triad of vascular, lung, and kidney infection with frequent 
involvement of oral cavity
• Demonstration of ANCA in the blood of the patient confi rms 
the diagnosis
• Oral biopsy shows pseudoepitheliomatous hyperplasia with 
subepithelial abscess formation.
MLG
MLG, fi rst described by McBride in 1897, is characterized 
by an idiopathic progressive destruction of face, palate, 
nose, paranasal sinuses, and pharynx.[7] Its exact etiology is 
unknown. Due to the presence of intense granulomatous 
infl ammation, it was thought to be a localized hypersensitivity 
phenomenon with tissue destruction. Both bacteria and 
Epstein-Barr virus infection are implicated in the pathogenesis 
of MLG. Currently, it is regarded as a localized form of 
angiocentric immunoproliferative lesions, characterized by 
massive necrosis. This is the pathological hallmark of MLG. It 
begins as a superfi cial ulceration of the palate or nasal septum, 
often preceded by a feeling of stuﬃ  ness in the nose, clinically 
resembling carcinoma. The ulceration spreads from palate to the 
nasal cavity and thence outside. Palatal, nasal, and malar bones 
may become involved, undergoing necrosis, and sequestration. 
The patient may exhibit purulent discharge from eyes and nose; 
perforating sinus tracts may develop, and much of the soft tissue 
of the face may slough away, leaving a direct opening into the 
nasopharynx and oral cavity. Histopathological examination 
reveals extensive necrosis with infl ammatory cell infi ltration and 
formation of new capillaries. The lesional process invades and 
destroys normal tissue in the area. Necrosis is often present in 
areas of the lesion, secondary to infi ltration of the blood vessels 
by the lesional cells.[34-37]
Key features facilitating diagnosis[34-37]
• Locally destructive, ulcerative lesions in the midline with no 
systemic involvement
• Necrosis, non-specifi c infl ammation with the absence of 
malignant epithelial cells.
Angioedema
Angioedema, also known as Quincke’s disease, is an acute 
edema of the mucosa or skin, characterized by an irregularly 
shaped swelling, which manifests itself episodically.[38] Certain 
allergens trigger the hypersensitivity reaction by binding to 
IgE, which causes release of histamine and other vasoactive 
substances in mast cells. Among medications, non-steroidal anti-
infl ammatory drugs, antibiotics, and antiepileptics frequently 
induce angioedema. It aﬀ ects women more frequently than men. 
Typical sites involved are lips, eyelid, genitals, and distal parts of 
extremities. The aﬀ ected skin becomes pale, sometimes slightly 
red. The swelling reaches its peak in several hours and dwindles. 
The whole process lasts between 8 and 72 h [Table 3].[39-41]
Key features facilitating diagnosis[38,41]
• Thorough history of the patient is essential to defi ne potential 
triggering factors
• Radioallergosorbent test is a blood test used to extract the 
exact allergen for the cause
• Scarifi cation test (scratching test) performed on the volar side of 
the forearm demonstrates hypersensitivity to various allergens.
Uveoparotid fever
Uveoparotid fever, also called uveoparotitis and Heerfordt’s 
syndrome, is a rare clinical condition, fi rst described by Heerfordt 
in 1909. Its defi nite cause is unknown.[5] A combination of 
environmental agents and a genetic predisposition is hypothesized 
in the pathogenesis of this disease. Mycobacterium and 
Propionibacterium species have been suggested as environmental 
agents, though the evidence is inconclusive. It is characterized by 
bilateral parotitis, uveitis, and mild fever, enlargement of lymph 
nodes and occasional cerebrospinal palsies. A patchy erythema of 
Table 3: Forms of angioedema[39]
Form of angioedema Characteristics
Hereditary 
angioedema (1-2%)
Autosomally dominant inherited 
genetic mutation aff ecting C1 INH 
protein or clotting factor XII
ACE inhibitor-induced 
angioedema (30%)
Delayed onset (days to months 
aft er the fi rst use of ACE inhibitor)
Idiopathic 
angioedema (38%)
Cause of angioedema is unknown; 





drugs, radiologic contrast 
media, and latex gloves)
ACE: Angiotensin-converting enzyme
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the skin has been reported in the early course of the disease. The 
most common eye lesion is uveitis, but keratitis, conjunctivitis, 
and corneal herpes have also been noted.[42,43]
Key features facilitating diagnosis[7,42,43]
• Triad of fever, bilateral parotitis, and uveitis
• Clinical history plays a key role in diagnosis.
Latex allergy
Natural latex is a product of the rubber tree, Hevia brasiliensis. The 
use of natural rubber latex gloves serves as a barrier and prevents 
transmission of infectious diseases including HIV and viral 
hepatitis. Dental surgeons, dental students, patients, and other 
health-care providers are at risk of latex allergy. Development 
of latex allergy depends on the quantity of the latex protein 
present on the latex material. The range of allergen protein varies 
between 220 and 12000 units (AU/ml of allergen), based on the 
latex brand. The following are mechanisms by which patients at 
risk can be sensitized:
• Intake of airborne latex allergen
• Oral mucosal contact with latex protein.
Contact urticaria is the most frequent manifestation and may 
be the only presentation preceding systemic manifestations. 
Skin rash and bronchospasm can occur subsequently. Latex 
is considered to be an occupational allergen and can cause 
occupational asthma in the people involved with the regular use 
of latex.[44-46]
Key features facilitating diagnosis[44-46]
• Diagnosis is based on thorough history and clinical suspicion
• Defi nitive diagnosis can be obtained through skin test and 
determination of antigen-specifi c IgE levels in the patient’s 
blood.
Conclusion
Allergic and immunologic diseases are common in the head 
and neck region. Oral manifestations are encountered with 
greater frequency and are often the fi rst clinical signs of these 
diseases. Dentists play a key role in recognizing the oral signs 
and symptoms and are instrumental in timely diagnosis and 
therapeutic intervention.[2] As some of these diseases have higher 
rates of morbidity and mortality, it is necessary to obtain an early 
diagnosis and refer the patient for further medical care. To aid 
in this process, an in-depth knowledge of these diseases helps in 
early recognition and facilitates a positive therapeutic outcome 
and disease prognosis. Optimal management of these conditions 
requires a multidisciplinary medical team consisting of physicians, 
dermatologists, dentists, and  ophthalmologists.[2,47]
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